DOCUMENT
65 -- Dipeptidyl-Peptidase 4 Inhibitors - Attachment
- Notice Date
- 6/28/2018
- Notice Type
- Attachment
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- VA National Acquisition Center - Department of Veterans Affairs National Acquisition Center
- Solicitation Number
- 36E79718R0034
- Response Due
- 7/12/2018
- Archive Date
- 10/19/2018
- Point of Contact
- Michael Olszewski
- Small Business Set-Aside
- N/A
- Description
- PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79718R0034 for an unrestrictive procurement for Dipeptidyl-Peptidase 4 Inhibitors for the Department of Veterans Affairs (VA). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E797P18R0034 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about July 02, 2018, with a tentative closing date of July 12, 2018. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: michael.olszewski@va.gov. Estimated annual quantities are as follows: This solicitation competes five Dipeptidyl-Peptidase 4 Inhibitors covered drugs with one award to be made on only one of the five DPP-4 Inhibitors. Offeror shall list all available strengths and package sizes they have available, a list of all available strengths and package sizes must be submitted with the submitted offer. ITEM DESCRIPTION VA ESTIMATED ANNUAL USAGE (TABLETS) 1 DPP-4 inhibitors *class includes the following · Alogliptin · Alogliption-Authorized Generic · Linagliptin · Saxagliptin · Sitagliptin 22,848,650
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/VA/VANAC/VANAC/36E79718R0034/listing.html)
- Document(s)
- Attachment
- File Name: 36E79718R0034 36E79718R0034_1.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=4443058&FileName=36E79718R0034-000.docx)
- Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=4443058&FileName=36E79718R0034-000.docx
- Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
- File Name: 36E79718R0034 36E79718R0034_1.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=4443058&FileName=36E79718R0034-000.docx)
- Record
- SN04972075-W 20180630/180628230824-93638d0a05b523bc093a239d2873dc85 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |